|
1
|
Pohl H and Welch HG: The role of
overdiagnosis and reclassification in the marked increase of
esophageal adenocarcinoma incidence. J Natl Cancer Inst.
19:142–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Surveillance Epidemiology and End Results.
http://seer.cancer.gov/csr/1975_2008/index.html
Updated November 2011.
|
|
3
|
Birkmeyer JD, Siewers AE, Finlayson EV, et
al: Hospital volume and surgical mortality in the United States. N
Engl J Med. 11:1128–1137. 2002.
|
|
4
|
Liu L, Hofstetter W, Rashid A, et al:
Significance of the depth of tumor invasion and lymph node
metastasis in superficially invasive (T1) esophageal
adenocarcinoma. Am J Surg Pathol. 29:1079–1085. 2005.PubMed/NCBI
|
|
5
|
Guarino M: Epithelial-mesenchymal
transition and tumour invasion. Int J Biochem Cell Biol.
39:2153–2160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Natalwala A, Spychal R and Tselepis C:
Epithelial-mesenchymal transition mediated tumourigenesis in the
gastrointestinal tract. World J Gastroenterol. 14:3792–3797. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spaderna S, Schmalhofer O, Hlubek F, et
al: A transient, EMT-linked loss of basement membranes indicates
metastasis and poor survival in colorectal cancer.
Gastroenterology. 131:830–840. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Usami Y, Satake S, Nakayama F, et al:
Snail-associated epithelial-mesenchymal transition promotes
oesophageal squamous cell carcinoma motility and progression. J
Pathol. 215:330–339. 2008. View Article : Google Scholar
|
|
9
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumors: accumulating evidence and unsolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizrak D, Brittan M and Alison MR: CD133:
molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin S, Li J, Hu C, et al: CD133 positive
hepatocellular carcinoma cells possess high capacity for
tumorigenicity. Int J Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prasad GA, Wu TT, Wigle DA, et al:
Endoscopic and surgical treatment of mucosal (T1a) esophageal
adenocarcinoma in Barrett’s esophagus. Gastroenterology.
137:815–823. 2009.
|
|
15
|
Jethwa P, Naqvi M, Hardy RG, et al:
Overexpression of Slug is associated with malignant progression of
esophageal adenocarcinoma. World J Gastroenterol. 14:1044–1052.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
17
|
Lagarde SM, ten Kate FJ, Reitsma JB, et
al: Prognostic factors in adenocarcinoma of the esophagus or
gastroesophageal junction. J Clin Oncol. 24:4347–4355. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hahn HP, Shahsafaei A and Odze RD:
Vascular and lymphatic properties of the superficial and deep
lamina propria in Barrett esophagus. Am J Surg Pathol.
32:1454–1461. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Badreddine RJ, Prasad GA, Lewis JT, et al:
Depth of submucosal invasion does not predict lymph node metastasis
and survival of patients with esophageal carcinoma. Clin
Gastroenterol Hepatol. 8:248–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Westerterp M, Koppert LB, Buskens CJ, et
al: Outcome of surgical treatment for early adenocarcinoma of the
esophagus or gastro-esophageal junction. Virchows Arch.
446:497–504. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Washington K, Chiappori A, Hamilton K, et
al: Expression of beta-catenin, alpha-catenin, and E-cadherin in
Barrett’s esophagus and esophageal adenocarcinomas. Mod Pathol.
11:805–813. 1998.
|
|
22
|
Oda T, Kanai Y, Oyama T, et al: E-cadherin
gene mutations in human gastric carcinoma cell lines. Proc Natl
Acad Sci USA. 91:1858–1862. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang MH, Chen CL, Chau GY, et al:
Comprehensive analysis of the independent effect of Twist and Snail
in promoting metastasis of hepatocellular carcinoma. Hepatology.
50:1464–1474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lowy AM, Knight J and Groden J:
Restoration of E-cadherin/beta-catenin expression in pancreatic
cancer cells inhibits growth by induction of apoptosis. Surgery.
132:141–148. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cano A, Pérez-Moreno MA, Rodrigo I, et al:
The transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Batlle E, Sancho E, Francí C, et al: The
transcription factor Snail is a repressor of E-cadherin gene
expression in epithelial tumour cells. Nat Cell Biol. 2:84–89.
2000. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vernon AE and LaBonne C: Tumor metastasis:
a new twist on epithelial - mesenchymal transitions. Curr Biol.
14:719–721. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Castanon I and Baylies MK: A Twist in
fate: evolutionary comparison of Twist structure and function.
Gene. 287:11–22. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Natsugoe S, Uchikado Y, Okumura H, et al:
Snail plays a key role in E-cadherin-preserved esophageal squamous
cell carcinoma. Oncol Rep. 17:517–523. 2007.PubMed/NCBI
|
|
30
|
Yuen HF, Chan YP, Wong ML, et al:
Upregulation of Twist in oesophageal squamous cell carcinoma is
associated with neoplastic transformation and distant metastasis. J
Clin Pathol. 60:510–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reya T, Morrison SJ, Clarke MF, et al:
Stem cells, cancer, and cancer stem cells. Nature. 414:105–111.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nowell PC: The clonal evolution of tumor
cell populations. Science. 194:23–28. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brabletz T, Jung A, Spaderna S, et al:
Opinion: migrating cancer stem cells - an integrated concept of
malignant tumour progression. Nat Rev Cancer. 5:744–749. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
